PHARMACOVIGILANCE OF HYPOLIPIDEMIC DRUGS - A RETROSPECTIVE STUDY OF THE DATA OF THE FRENCH SYSTEM OF PHARMACOVIGILANCE

被引:0
|
作者
LAVARENNE, J
机构
来源
THERAPIE | 1991年 / 46卷 / 05期
关键词
ADVERSE EFFECTS; HYPOLIPIDEMIC DRUGS; FIBRATES; DATA-BANK;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The methodology of a retrospective study of the side-effects of the most prescribed lipid lowering drugs, essentially fibrates, is described. This study concerns the last 5-years reports to the French System of Pharmacovigilance, centralized in the common data-base located in Lyon. During this period 36 875 reports were recorded, only 409 in which an hypolipidemic drug is stated as "suspect" (according to WHO's definitions) were selected and analyzed. All fibrates were involved, those most frequently implicated being the most widely prescribed (e.g. fenofibrate represents half of the reports).
引用
收藏
页码:345 / 346
页数:2
相关论文
共 50 条
  • [31] Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study
    Kumar Sr, Raj
    Jindal Sr, Amita
    Garg, Pardeep
    Kaur, Amandeep
    Kumar, Sumir
    Raj, Rakesh Tilak
    Singh, Simrandeep
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [33] Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance data report
    Bihan, K.
    Lipszyc, L.
    Lemaitre, F.
    Dautriche, A.
    Fedrizzi, S.
    Atzenhoffer, M.
    Vitores, A.
    Page, A.
    Lebrun-Vignes, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 81 - 81
  • [34] Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database
    Faisant, Charles
    Armengol, Guillaume
    Bouillet, Laurence
    Boccon-Gibod, Isabelle
    Villier, Celine
    Levesque, Herve
    Cottin, Judith
    Massy, Nathalie
    Benhamou, Ygal
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (01) : 95 - 102
  • [35] Atorvastatin and Memory Impairment: Analysis of French Pharmacovigilance Data
    Lepoix, E.
    Martin, S.
    Laoulaou, B.
    Morel, A.
    Trenque, T.
    Azzouz, B.
    DRUG SAFETY, 2021, 44 (12) : 1429 - 1429
  • [36] DRUGS RELATED BONE LOSS: A CASE/NONCASE STUDY IN THE FRENCH AND SPANISH PHARMACOVIGILANCE DATABASES
    Perez-Lloret, S.
    Salgueiro-Vazquez, M. E.
    Rey, M. V.
    Abadie, D.
    Manso, G.
    Montastruc, J. L.
    Bagheri, H.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S220 - S220
  • [37] Drugs and retinal disorders: a case/non-case study in the French PharmacoVigilance Database
    Bourgeois, N.
    Chavant, F.
    Leveziel, N.
    Auriche, P.
    Andrejak, M.
    Sgro, C.
    Jean-Pastor, M. J.
    Hilaire, D.
    Ingrand, I.
    Perault-Pochat, M. C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 53 - 53
  • [38] Drugs associated with suicide: case/non-case study in the French Pharmacovigilance Database
    Miet, J. P.
    Fleck, C.
    Pinzani, V.
    Lepelley, M.
    Dautriche, A.
    Grandvuillemin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 37 - 37
  • [39] Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database
    Charles Faisant
    Guillaume Armengol
    Laurence Bouillet
    Isabelle Boccon-Gibod
    Céline Villier
    Hervé Lévesque
    Judith Cottin
    Nathalie Massy
    Ygal Benhamou
    Journal of Clinical Immunology, 2016, 36 : 95 - 102
  • [40] Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
    Coulter, DM
    Bate, A
    Meyboom, RHB
    Lindquist, M
    Edwards, IR
    BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7296): : 1207 - 1209